Voloridge Investment Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-558,768
| Closed | -$71.6M | – | 1192 |
|
|
2025
Q2 | $71.6M | Buy |
558,768
+548,633
| +5,413% | +$57M | 0.26% | 97 |
|
|
2025
Q1 | $897K | Sell |
10,135
-203,562
| -95% | -$19.9M | ﹤0.01% | 1057 |
|
|
2024
Q4 | $18.6M | Sell |
213,697
-73,863
| -26% | -$6.77M | 0.07% | 365 |
|
|
2024
Q3 | $26.6M | Buy |
287,560
+60,980
| +27% | +$6.06M | 0.1% | 304 |
|
|
2024
Q2 | $24.4M | Buy |
226,580
+8,144
| +4% | +$815K | 0.09% | 305 |
|
|
2024
Q1 | $20.7M | Buy |
218,436
+77,447
| +55% | +$6.64M | 0.08% | 322 |
|
|
2023
Q4 | $13M | Buy |
+140,989
| New | +$9.14M | 0.05% | 416 |
|
|
2023
Q2 | – | Sell |
-41,352
| Closed | -$1.86M | – | 1365 |
|
|
2023
Q1 | $1.86M | Buy |
+41,352
| New | +$1.86M | 0.01% | 994 |
|
|
2022
Q4 | – | Sell |
-40,927
| Closed | -$2.7M | – | 1442 |
|
|
2022
Q3 | $2.7M | Sell |
40,927
-17,205
| -30% | -$1.11M | 0.01% | 890 |
|
|
2022
Q2 | $2.94M | Buy |
+58,132
| New | +$3.41M | 0.02% | 885 |
|
|
2021
Q3 | – | Sell |
-26,268
| Closed | -$2.31M | – | 1656 |
|
|
2021
Q2 | $2.31M | Buy |
26,268
+6,693
| +34% | +$613K | 0.02% | 941 |
|
|
2021
Q1 | $1.9M | Sell |
19,575
-100,529
| -84% | -$10M | 0.01% | 841 |
|
|
2020
Q4 | $13.5M | Buy |
120,104
+102,554
| +584% | +$10.8M | 0.11% | 217 |
|
|
2020
Q3 | $1.63M | Buy |
+17,550
| New | +$1.35M | 0.01% | 786 |
|
|
2020
Q2 | – | Sell |
-4,454
| Closed | -$260K | – | 1259 |
|
|
2020
Q1 | $260K | Sell |
4,454
-8,428
| -65% | -$542K | 0.01% | 901 |
|
|
2019
Q4 | $1.03M | Buy |
+12,882
| New | +$964K | 0.02% | 646 |
|
|
2019
Q3 | – | Sell |
-23,450
| Closed | -$2.21M | – | 1058 |
|
|
2019
Q2 | $2.21M | Buy |
+23,450
| New | +$1.94M | 0.06% | 308 |
|
|
2017
Q3 | – | Sell |
-31,800
| Closed | -$1.61M | – | 391 |
|
|
2017
Q2 | $1.61M | Buy |
+31,800
| New | +$1.35M | 0.04% | 287 |
|
Other funds holding BPMC
IA
HNB
Voloridge Investment Management's BPMC Position: Q3 2025 in Review
Voloridge Investment Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 558,768 shares — an estimated $71.6M sold.
Voloridge Investment Management first reported a position in BPMC in Q2 2017 and held it in 18 quarters. The position peaked at $71.6M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Voloridge Investment Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Voloridge Investment Management sold 558,768 Blueprint Medicines shares in Q3 2025, an estimated $71.6M.
- Voloridge Investment Management first reported a position in Blueprint Medicines in Q2 2017 and held it in 18 quarters.
- Voloridge Investment Management's Blueprint Medicines position peaked at $71.6M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.